Skip to main content
. 2020 Jul;21(7):571–580. doi: 10.1631/jzus.B1900624

Fig. 3.

Fig. 3

In vitro release profiles of PTX suspension, NLC/PTX and HA-NLC/PTX

PTX: paclitaxel; NLC: nano-structured lipid carrier; HA-NLC: hyaluronic acid-octadecylamine (HA-ODA)-modified NLC. Data were expressed as mean±SD (n=3)